CClinicalTrials.gg
CompletedNCT02222337Updated Jun 3, 2019Results posted

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

An interventional study of Nueva Vida Intervention in Quality of Life and Breast Cancer, sponsored by Georgetown University. Completed at 4 sites in United States. Open to participants aged Up to 85 Years. Per ClinicalTrials.gov, last updated 2019-06-03.

Sponsored by Georgetown University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
272
Allocation
Randomized
Ages
Up to 85 Years
Sex
All
01

Study summary

Latina breast cancer survivors report lower quality of life (QOL) than non-Latina survivors. Lower QOL can lead to poorer functional and cancer-related survival outcomes. The friends and family of Latina cancer patients are also impacted by a loved one's diagnosis of breast cancer. Through strong community-academic partnerships, the investigators seek to improve the QOL of Latina survivors and their caregivers with a culturally-relevant intervention. In this project, the investigators plan to further develop and refine the intervention and then test it through a randomized controlled trial. First, the investigators will conduct in-depth qualitative interviews with 10 survivor-caregiver dyads (pairs) to see if the intervention fits for survivors and caregivers in different parts of the country. Then, the investigators will revise the intervention. Finally, the investigators will test the intervention in a randomized controlled trial. The investigators will invite 125 survivor-caregiver dyads to be a part of our study. Half will be asked to complete the intervention and half will be offered the usual services, such as support groups. The information learned from this study could help improve the quality of life in Latina breast cancer survivors and their caregivers. Physicians, survivors, and community groups can also benefit from this study because they will have more information about the needs of Latina breast cancer survivors. The investigators hope to use the information to help other types of survivors and caregivers in the future.

Read the detailed description

What is the Nueva Vida Intervention? The "Nueva Vida Intervention: Improving Quality of Life in Latina Breast Cancer Survivors and Their Caregivers" is a randomized controlled trial (RCT) that was co-developed by a Latina breast cancer survivor who is trained as a mental health professional. The program was developed for Nueva Vida, a community-based organization (CBO) in the Washington, DC metropolitan area that serves Latina breast cancer survivors and their families. We are comparing the intervention to the usual services provided at our four partner community-based organizations.

How is the Nueva Vida Intervention Structured? The 8-session psycho-educational quality of life intervention includes group-based skill-building workshops in which Latina survivors and their caregivers are part of concurrently-held but separate groups (survivors in one room; caregivers in another). This separation meets the needs of Latino participants by encouraging them to freely share their experiences and feelings without worrying about upsetting the other person. Five of the eight sessions address core topics: Introduction and The Impact of Cancer on the Family, Stress Management, Improving Communication: Family, Friends, and Providers, Spirituality and Cancer, and Balancing Physical and Emotional Needs.

The remaining three sessions are selected by the intervention participants based on their own needs and interests from the following options: Anger Management, Intimacy after Cancer: Emotional and Sexual, Trauma and Cancer, Role Changes, Understanding Distress and Depression, Myths and Cancer, Including Others in Helping Caregivers, and Putting Our Lives in Order. At the end of the intervention everyone participates in a graduation ceremony.

How does the Nueva Vida Intervention Reflect Latino Values? The Nueva Vida intervention reflects Latino values, including personalismo (warm, personal relationships), familismo (emphasizing the family unit in managing a cancer diagnosis) and framing the sessions as workshops to avoid stigma associated with mental health care.

Where will the Nueva Vida Intervention Study take place? We will evaluate the Nueva Vida Intervention within a multi-site RCT at four community-based organizations in Washington, DC (Nueva Vida), New York, New York (SHARE, Gilda's Club New York City), and San Jose, California (Latinas Contra Cancer).

What is Involved in Study Participation? Latina survivors and their caregivers will be assigned by chance (randomized) to either the Nueva Vida Intervention or to usual care. Survivors and caregivers assigned to usual care can take part in any and all of the services provided at one of the four community-based organizations who are study partners. Both survivors and caregivers will complete informed consent forms and telephone surveys at the beginning of the study, about 4 months later, and again 6 months later. Survivors and caregivers receive gift cards in appreciation of their time for completing the surveys.

02

Conditions studied

  • Quality of Life
  • Breast Cancer

Browse trials for

Keywords

  • behavioral intervention
  • quality of life
  • breast cancer
  • Latina
  • caregiver
  • PCORI
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 272 is above the median of 72 across 9,302 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Georgetown University is the lead sponsor of 286 studies on the registry; 42 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 20 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Survivors: Latina, has been diagnosed with breast cancer, speaks English or Spanish, has a Caregiver who is willing to participate.
  • Caregivers: a primary caregiver for a Latina breast cancer survivor, speak English or Spanish

Exclusion criteria

Exclusion Criteria:

  1. Inability to understand spoken English and/or Spanish and/or
  2. Cognitive impairment that precludes informed consent (determined by the PIs or Co-Investigators who are mental health professionals).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
272 participants (actual)

Study arms

  • Active comparator
    Nueva Vida Intervention

    Nueva Vida Intervention consists of 8 sessions of a skills-building group held twice a month for 4 months. Latina survivors and their caregivers arrive at the group together, separate into different rooms to learn the coping and communication skills, and then join together for discussion of the topic.

    Behavioral: Nueva Vida Intervention

  • No intervention
    Usual Care

    Usual care as provided by each of our 4 community-based organization partners. Usual care can include but is not limited to support groups, patient navigation, individual, couple or family therapy.

Interventions

  • BehavioralNueva Vida Intervention

    The psycho-educational format of the Nueva Vida Intervention is led by trained interventionists who have the survivors and caregivers go into different rooms to discuss the same topic. This format will allows them each to express their thoughts and feelings without inhibitions or concerns over how their survivor or their caregiver might respond. The specific topics for each wave of the intervention participants will be determined from a larger list of possible topics, with each group including the following core topics: Impact of Cancer on the Family, Spirituality and Cancer, Stress Management, Balancing Physical and Emotional Needs and Improving Communication.

06

What researchers measure

Primary outcomes

  1. PROMIS Physical Functioning

    Measure Quality of Life physical functioning; 6 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10. Range of the raw score = 6-28; A higher score = higher physical functioning

    Time frame: 6 months

  2. PROMIS Satisfaction With Social Roles

    Measure Quality of Life satisfaction with social roles domain; 6 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10; Range of the raw score = 6-30; A higher score = higher satisfaction with social roles

    Time frame: 6 months

  3. PROMIS Anxiety

    Quality of life: Anxiety; 6 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10. Range of the raw score = 6 to 30. A higher score = higher anxiety

    Time frame: 6 months

  4. PROMIS Depression

    Quality of life: depression; 6 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10. Range of the raw score = 6-30; A higher score = higher depression

    Time frame: 6 months

  5. PROMIS Fatigue

    Quality of life: fatigue; 4 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10. Range of the raw score = 4-20; A higher score = higher fatigue

    Time frame: 6 months

Secondary outcomes

  1. Communication - Survivors Only - Patient Satisfaction With Care (PSQ-18 Communication Subscale)

    Communication with providers in terms of overall satisfaction with communication. Range for subscale is 1-5; higher scores indicate higher communication satisfaction.

    Time frame: 6-months

  2. Self-Efficacy - Survivors Only - Cancer Behavior Inventory (CBI)

    Self-efficacy; cancer survivors' confidence in coping with cancer and its treatment

    Time frame: 6 Months

  3. Satisfaction With Care - Survivors Only - Experience of Care and Health Outcomes (ECHOS-NHL)

    Satisfaction with health care received by the breast cancer survivor from her oncology health care providers or general health care providers

    Time frame: 6-months

07

Results

Posted Jun 3, 2019
Limitations and caveats
Difficulty tracking all approached and eligible participants in terms of number of individuals who declined the study due to recruitment at multiple community events and community sites.

Participant flow

Participant flow — Overall Study
MilestoneNueva Vida InterventionUsual Care
Started140132
Completed114108
Not completed2624

Outcome measures

PrimaryPROMIS Physical Functioning

Measure Quality of Life physical functioning; 6 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10. Range of the raw score = 6-28; A higher score = higher physical functioning

Time frame:
6 months
Reported as:
Mean · units on a scale
PROMIS Physical Functioning
units on a scaleUsual Care SurvivorsUsual Care CaregiversNueva Vida Intervetion SurvivorsNueva Vida Intervention Caregivers
PROMIS Physical Functioning44.61 ± 8.7153.82 ± 7.3445.07 ± 9.2052.99 ± 7.70
PrimaryPROMIS Satisfaction With Social Roles

Measure Quality of Life satisfaction with social roles domain; 6 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10; Range of the raw score = 6-30; A higher score = higher satisfaction with social roles

Time frame:
6 months
Reported as:
Mean · units on a scale
PROMIS Satisfaction With Social Roles
units on a scaleUsual Care SurvivorsUsual Care CaregiversNueva Vida Intervetion SurvivorsNueva Vida Intervention Caregivers
PROMIS Satisfaction With Social Roles52.84 ± 10.1158.64 ± 5.9354.07 ± 9.8759.45 ± 6.75
PrimaryPROMIS Anxiety

Quality of life: Anxiety; 6 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10. Range of the raw score = 6 to 30. A higher score = higher anxiety

Time frame:
6 months
Reported as:
Mean · units on a scale
PROMIS Anxiety
units on a scaleUsual Care SurvivorsUsual Care CaregiversNueva Vida Intervetion SurvivorsNueva Vida Intervention Caregivers
PROMIS Anxiety53.93 ± 12.0448.41 ± 8.6150.90 ± 11.9948.70 ± 8.76
PrimaryPROMIS Depression

Quality of life: depression; 6 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10. Range of the raw score = 6-30; A higher score = higher depression

Time frame:
6 months
Reported as:
Mean · units on a scale
PROMIS Depression
units on a scaleUsual Care SurvivorsUsual Care CaregiversNueva Vida Intervetion SurvivorsNueva Vida Intervention Caregivers
PROMIS Depression47.43 ± 9.4643.95 ± 7.1647.35 ± 11.1344.49 ± 7.48
PrimaryPROMIS Fatigue

Quality of life: fatigue; 4 items; Sum and then use IRT to standardize the score. Mean of 50; SD of 10. Range of the raw score = 4-20; A higher score = higher fatigue

Time frame:
6 months
Reported as:
Mean · units on a scale
PROMIS Fatigue
units on a scaleUsual Care SurvivorsUsual Care CaregiversNueva Vida Intervetion SurvivorsNueva Vida Intervention Caregivers
PROMIS Fatigue49.07 ± 12.8553.06 ± 12.3847.83 ± 10.4846.68 ± 10.77
SecondaryCommunication - Survivors Only - Patient Satisfaction With Care (PSQ-18 Communication Subscale)

Communication with providers in terms of overall satisfaction with communication. Range for subscale is 1-5; higher scores indicate higher communication satisfaction.

Time frame:
6-months
Reported as:
Mean · units on a scale
Communication - Survivors Only - Patient Satisfaction With Care (PSQ-18 Communication Subscale)
units on a scaleNueva Vida InterventionUsual Care
Communication - Survivors Only - Patient Satisfaction With Care (PSQ-18 Communication Subscale)3.52 ± 1.943.23 ± 1.69
SecondarySelf-Efficacy - Survivors Only - Cancer Behavior Inventory (CBI)

Self-efficacy; cancer survivors' confidence in coping with cancer and its treatment

Time frame:
6 Months
Reported as:
Mean · units on a scale
Self-Efficacy - Survivors Only - Cancer Behavior Inventory (CBI)
units on a scaleNueva Vida InterventionUsual Care
Self-Efficacy - Survivors Only - Cancer Behavior Inventory (CBI)106.96 ± 19.59107.96 ± 17.35
SecondarySatisfaction With Care - Survivors Only - Experience of Care and Health Outcomes (ECHOS-NHL)

Satisfaction with health care received by the breast cancer survivor from her oncology health care providers or general health care providers

Time frame:
6-months
Reported as:
Mean · units on a scale
Satisfaction With Care - Survivors Only - Experience of Care and Health Outcomes (ECHOS-NHL)
units on a scaleNueva Vida InterventionUsual Care
Satisfaction With Care - Survivors Only - Experience of Care and Health Outcomes (ECHOS-NHL)35.04 ± 4.4834.63 ± 4.38

Adverse events

Collected over Adverse event data were collected from time of enrollment through 6-month follow-up (3 years).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Nueva Vida Intervention1/140 (0.7%)0/140 (0%)0/140 (0%)
Usual Care2/130 (1.5%)0/130 (0%)0/130 (0%)

Baseline characteristics

Two participants enrolled in the study but withdrew prior to the baseline interview (thus, N = 130). Baseline analysis was conducted by 1) randomization, and 2) participant type. Data was missing for certain measures; numbers analyzed are adjusted accordingly.

Age, Categorical
Age, Categorical(Participants)Nueva Vida InterventionUsual CareTotal
Survivors — <=18 years000
Survivors — Between 18 and 65 years5956115
Survivors — >=65 years10919
Caregivers — <=18 years000
Caregivers — Between 18 and 65 years6157118
Caregivers — >=65 years6612
Sex: Female, Male
Sex: Female, Male(Participants)Nueva Vida InterventionUsual CareTotal
Survivors — Female7065135
Survivors — Male000
Caregivers — Female423880
Caregivers — Male282755
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Nueva Vida InterventionUsual CareTotal
Survivors — Hispanic or Latino7065135
Survivors — Not Hispanic or Latino000
Survivors — Unknown or Not Reported000
Caregivers — Hispanic or Latino6964133
Caregivers — Not Hispanic or Latino011
Caregivers — Unknown or Not Reported101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Nueva Vida InterventionUsual CareTotal
Survivors — American Indian or Alaska Native000
Survivors — Asian000
Survivors — Native Hawaiian or Other Pacific Islander000
Survivors — Black or African American358
Survivors — White221739
Survivors — More than one race283159
Survivors — Unknown or Not Reported171128
Caregivers — American Indian or Alaska Native000
Caregivers — Asian000
Caregivers — Native Hawaiian or Other Pacific Islander000
Caregivers — Black or African American011
Caregivers — White192140
Caregivers — More than one race252247
Caregivers — Unknown or Not Reported262147
Satisfaction with Care Experience of Care and Health Outcomes (ECHOS-NHL)
Satisfaction with Care Experience of Care and Health Outcomes (ECHOS-NHL)(units on a scale)Nueva Vida InterventionUsual CareTotal
Mean33.68 ± 5.8734.35 ± 4.8834 ± 5.41
Self-Efficacy - Survivors Only - Cancer Behavior Inventory (CBI)
Self-Efficacy - Survivors Only - Cancer Behavior Inventory (CBI)(units on a scale)Nueva Vida InterventionUsual CareTotal
Mean100.07 ± 21.28101.60 ± 19.11100.81 ± 20.2
Communication - Patient Satisfaction with Care (PSQ-18 Communication Subscale)
Communication - Patient Satisfaction with Care (PSQ-18 Communication Subscale)(units on a scale)Nueva Vida InterventionUsual CareTotal
Mean2.28 ± 0.912.28 ± 0.932.28 ± 0.92
PROMIS Anxiety
PROMIS Anxiety(units on a scale)Nueva Vida InterventionUsual CareTotal
Survivors54.3 ± 12.9752.94 ± 9.9553.65 ± 11.59
Caregivers51.9 ± 9.7650.35 ± 9.2651.15 ± 9.52

4 further baseline measures are reported on the registry.

08

Study locations

4 sites
  • Latinas Contra Cancer
    San Jose, California 95110, United States
  • Nueva Vida
    Washington, District of Columbia 20007, United States
  • Gilda's Club New York City
    New York, New York 10014, United States
  • SHARE
    New York, New York 95110, United States
09

References and documents

Publications

  • Rush CL, Darling M, Elliott MG, Febus-Sampayo I, Kuo C, Munoz J, Duron Y, Torres M, Galvan CC, Gonzalez F, Caicedo L, Napoles A, Jensen RE, Anderson E, Graves KD. Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention. Qual Life Res. 2015 May;24(5):1107-18. doi: 10.1007/s11136-014-0847-9. Epub 2014 Nov 8. PubMed 25377349 ↗

Study documents

  • Informed consent form · Jul 8, 2015
  • Protocol and statistical analysis plan · Dec 17, 2012

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02222337
Lead sponsor
Georgetown University
Collaborators
Nueva Vida, Inc., Latinas Contra Cancer, Gilda's Club NYC, SHARE
Responsible party
Kristi Graves, PhD (Associate Professor, Georgetown University) — Principal investigator
First posted
Aug 21, 2014
Start date
May 2013
Primary completion
Jan 24, 2017
Completion
Dec 2017
Results posted
Jun 3, 2019
Last update
Jun 3, 2019

Study contacts

Kristi D Graves, Ph.D.
principal investigator · Georgetown University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion